Hoya Corp. (OTCMKTS:HOCPY – Get Free Report) shares gapped up before the market opened on Thursday. The stock had previously closed at $165.88, but opened at $173.13. Hoya shares last traded at $165.30, with a volume of 627 shares traded.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised shares of Hoya from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 30th. One investment analyst has rated the stock with a Strong Buy rating. According to MarketBeat, the company presently has a consensus rating of “Strong Buy”.
Get Our Latest Report on HOCPY
Hoya Stock Performance
The company has a market cap of $56.00 billion, a P/E ratio of 33.18, a PEG ratio of 3.44 and a beta of 0.97. The company has a 50 day moving average price of $154.61 and a 200-day moving average price of $163.13. The company has a quick ratio of 4.20, a current ratio of 4.91 and a debt-to-equity ratio of 0.03.
Hoya (OTCMKTS:HOCPY – Get Free Report) last issued its quarterly earnings results on Friday, July 31st. The technology company reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.13 by $0.10. Hoya had a return on equity of 25.78% and a net margin of 27.58%. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.55 billion. Equities analysts expect that Hoya Corp. will post 5.26 EPS for the current fiscal year.
About Hoya
HOYA Corporation is a Japan-based technology and healthcare company that develops and manufactures optical products and precision components. Founded in 1941 as an optical glass manufacturer, the company has expanded into medical devices, vision care, and advanced technologies used in semiconductor production and other industrial applications.
Through its Life Care businesses, HOYA provides prescription eyeglass lenses, contact lenses, intraocular lenses used in cataract surgery, and medical equipment such as endoscopic systems.
See Also
- Five stocks we like better than Hoya
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.
